ClearPoint Neuro (CLPT) Intangibles (2012 - 2026)

ClearPoint Neuro's (CLPT) quarterly Intangibles came in at $13.4 million in Q1 2026, down 3.61% quarter-over-quarter from $13.9 million in Q4 2025.

ClearPoint Neuro (CLPT) Intangibles (2012 - 2026) Analysis & Trends

ClearPoint Neuro has disclosed Intangibles across 5 years of filings, most recently posting $13.4 million for Q1 2026.

Intangibles for Q1 2026 came in at $13.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $13.4 million (changed N/A YoY), and the FY2025 annual result was $13.9 million, changed N/A from the prior year.
Intangibles came in at $13.4 million for Q1 2026 at ClearPoint Neuro, down from $13.9 million in the prior quarter.
In the past five years, Intangibles ranged from a high of $13.9 million in Q4 2025 to a low of $13.4 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	17.88 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	5.52 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	10.34 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	7.06 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	1.23 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	3.14 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	62.60 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	1.91 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.62 Bn
10	ClearPoint Neuro	524.46 Mn	488.86 Mn	7.76 Mn	13.42 Mn

Download Data